ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

AACR Presents Awards at Annual Meeting

April 5, 2013

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995